Identification of adeno-associated virus variants for gene transfer into human neural cell types by parallel capsid screening
Abstract Human brain cells generated by in vitro cell programming provide exciting prospects for disease modeling, drug discovery and cell therapy. These applications frequently require efficient and clinically compliant tools for genetic modification of the cells. Recombinant adeno-associated virus...
Main Authors: | Lea Jessica Flitsch, Kathleen Börner, Christian Stüllein, Simon Ziegler, Vera Sonntag-Buck, Ellen Wiedtke, Vesselina Semkova, Si Wah Christina Au Yeung, Julia Schlee, Mohamad Hajo, Mona Mathews, Beatrice Stefanie Ludwig, Susanne Kossatz, Horst Kessler, Dirk Grimm, Oliver Brüstle |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-12404-0 |
Similar Items
-
Modifying immune responses to adeno-associated virus vectors by capsid engineering
by: Martin Bentler, et al.
Published: (2023-09-01) -
Natural Adeno-Associated Virus Serotypes and Engineered Adeno-Associated Virus Capsid Variants: Tropism Differences and Mechanistic Insights
by: Estrella Lopez-Gordo, et al.
Published: (2024-03-01) -
Adeno-associated viral capsid stability on anion exchange chromatography column and its impact on empty and full capsid separation
by: Ohnmar Khanal, et al.
Published: (2023-12-01) -
Capsid-mediated control of adeno-associated viral transcription determines host range
by: Ezra J. Loeb, et al.
Published: (2024-03-01) -
Capsid-modified adeno-associated virus vectors as novel vaccine platform for cancer immunotherapy
by: Ann-Christin Franke, et al.
Published: (2023-06-01)